Author

Tegan M. Rowsell

Moffitt Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Garima PandeyiD· 1 shared Gary W. ReutheriD· 1 shared Lucia MazzacuratiiD· 1 shared Narmin E. AminiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Garima PandeyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Modulation of the sensitivity to ruxolitinib-mediated JAK2 inhibition by mutationally activated SHP2 exhibits cell context dependency in pre-clinical models of myeloproliferative neoplasms

Tegan M. Rowsell, Garima Pandey, Lucia Mazzacurati, Narmin E. Amin, Gary W. Reuther

This study shows that an activating SHP2 mutation in MPN cell models alters sensitivity to JAK2 inhibition, with context-dependent effects observed in different cell lines.

bioRxiv · Aug 20, 2026 · PreprintCancer Biology